cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Clinical trial NCT05366881 · RECRUITING

Trial details

NCT number: NCT05366881
Sponsor: Adela, Inc
Status: RECRUITING
Study type: OBSERVATIONAL

Brain Cancer Breast Cancer Bladder Cancer Cervical Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer Stomach Cancer Head and Neck Cancer Hepatobiliary Cancer Leukemia Lung Cancer

Start date: 2022-05-03
Primary completion: 2026-03-01
Enrollment: 7000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.